The global CAR T-cell therapy market is experiencing significant growth, fueled by increasing acceptance of this innovative therapy for a range of diseases. Key drivers shaping the market include rising prevalence of cancer, advancements in science, and supportive regulations. The market is characterized by a competitive landscape with several pla